Insider Deck research · Earnings

ABBV earnings · AbbVie Inc.

AbbVie Inc. (ABBV) earnings history, EPS vs consensus, beat rate, forward estimates, and transcripts on Insider Deck. Latest print Q2 '26: EPS $3.65 vs consensus $3.61. Beat rate 75% across 4 prints. Next listed date 2026-10-29.

Latest EPS$3.65+0.0% surprise

Beat rate75%1 print streak

Avg surprise+0.0%vs consensus

Next printOct 29, 2026EPS $3.87

Quarterly EPS vs consensus

4 quarters

Actual ConsensusLabels: beat $ · YoY %Revisions 18 up / 28 down

Earnings transcripts

Read management commentary and analyst Q&A.

No transcript dates are available yet for this ticker.

Forward estimates

Consensus expectations and estimate momentum.

PeriodEPSRevenueGrowth

0QSep 2026

$3.87$17.3B+108.2%

+1QDec 2026

$3.96$18.2B+46.0%

0YDec 2026

$14.12$67.6B+41.2%

+1YDec 2027

$16.36$73.1B+15.9%

Primary research

Recent company filings

Jump directly to earnings releases, quarterly reports, and material updates.

Frequently asked questions

When is the next ABBV earnings date?

The next listed earnings date for ABBV is 2026-10-29. Dates can move — confirm on the earnings desk.

What is ABBV's earnings beat rate?

ABBV has beaten consensus on roughly 75% of recent prints in the Insider Deck sample.

Where are ABBV earnings call transcripts?

Ready transcripts appear under ABBV earnings as /stocks/us/abbv/earnings/{year}/q{n}.

Where can I research ABBV on Insider Deck?

AbbVie Inc. (ABBV) research covers KPIs, earnings, fundamentals, institutional ownership, 13F flow, news, and DCF valuation.